PHARMASUM THERAPEUTICS AS

Pharmasum Therapeutics - Home

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: AF
Anders Kohler Fugelli1968
Chairman of the board: AF
Anders Kohler Fugelli1968
Years since formation: 10 years; since Jun 17, 2014
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 3,166,419; 1 share class
Total number of shareholders: 683; 195 companies, 488 persons

Financials

Total operating income 2023: 1,379,500; NOK
Annual total result 2023: -1,750,939; NOK
Total equity 2023: 2,785,322; NOK

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
AF Anders Kohler Fugelli 1968	Managing Director/CEO	10.95 % directly 3.04 % indirectly 7.9 %

Board

Name	Role	Shares
AF Anders Kohler Fugelli 1968	Chairman	10.95 % directly 3.04 % indirectly 7.9 %
ØS Øystein Soug 1969	Board Member	-
JS John Sigurd Mjøen Svendsen 1958	Board Member	4.34 % directly 0.26 % indirectly 4.08 %
RJ Reijo Juhani Salonen 1956	Board Member	-
TB Tone Bjørnov 1961	Board Member	-

Others

Name	Role	Shares
P PRICEWATERHOUSECOOPERS AS	Auditor	-
T TANDEM AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
JH Jakob Hatteland 1951	-	17.25 % indirectly
AF Anders Kohler Fugelli 1968	Managing Director/CEO, Chairman	10.95 % directly 3.04 % indirectly 7.9 %
JS John Sigurd Mjøen Svendsen 1958	Board Member	4.34 % directly 0.26 % indirectly 4.08 %
WG Wenche Gunvor Berg Stensen 1956	-	4.08 % indirectly
BE Bernt Endrerud 1955	-	2.16 % indirectly
TH Tommy Hatteland 1990	-	1.88 % indirectly
SH Stig Hatteland 1980	-	1.88 % indirectly
ØH Øystein Hatteland 1992	-	1.88 % indirectly
RH Randi Hatteland 1978	-	1.88 % indirectly
RH Ronny Hatteland 1988	-	1.88 % indirectly

Last update: Aug 26, 2024

Ownership

Company shareholders

Name	Share class	Number of shares	Share
J JAHATT AS	Ordinary shares	485,085	15.32 %
J JAKOB HATTELAND HOLDING AS	Ordinary shares	414,954	13.1 %
P PHARMAPATENT AS	Ordinary shares	258,340	8.16 %
F FUGELLI INVEST AS	Ordinary shares	250,250	7.9 %
I INVEN2 AS	Ordinary shares	103,448	3.27 %
AF Anders Kohler Fugelli 1968	Ordinary shares	96,307	3.04 %
N NORTH MURRAY AS	Ordinary shares	76,930	2.43 %
P PHARMA HOLDINGS AS	Ordinary shares	68,142	2.15 %
H HEYERN AS	Ordinary shares	67,560	2.13 %
B BENT ERIKSEN AS	Ordinary shares	63,800	2.01 %
O O2h Venture Ltd	Ordinary shares	41,941	1.32 %
MO Mary Sylvia Olsen 1952	Ordinary shares	41,666	1.32 %
BH Bengt Kenneth Holmgren 1944	Ordinary shares	38,333	1.21 %
T TAJ HOLDING AS	Ordinary shares	37,616	1.19 %
P PICASSO AS	Ordinary shares	37,099	1.17 %
C CARE HOLDING AS	Ordinary shares	36,044	1.14 %
D DREXCIYA AS	Ordinary shares	34,483	1.09 %
EO Esben Omre 1953	Ordinary shares	33,333	1.05 %
BJ Bernt Roar Jansrud 1955	Ordinary shares	32,000	1.01 %
L LUKAS I AS	Ordinary shares	30,000	0.95 %
RV Roar Vike 1935	Ordinary shares	25,000	0.79 %
N NORINNOVA INVEST AS	Ordinary shares	23,362	0.74 %
S SYNOVIA AS	Ordinary shares	21,800	0.69 %
SG Sigurd Gjelsnes 1944	Ordinary shares	21,666	0.68 %
SH Sigmund Ingebrigt Hoel 1942	Ordinary shares	20,833	0.66 %
AA Arvid Askautrud 1940	Ordinary shares	20,833	0.66 %
KR Kannathasan Rasiah 1969	Ordinary shares	20,833	0.66 %
PV Petra Gunnvor Varder 1933	Ordinary shares	20,833	0.66 %
RK Rune Klavenes 1980	Ordinary shares	20,833	0.66 %
JV Johan Edvard Varder 1933	Ordinary shares	20,833	0.66 %
C CHIVIRICO AS	Ordinary shares	20,833	0.66 %
PJ Per Jørgen Lerud 1943	Ordinary shares	20,833	0.66 %
L LYSNES INVEST AS	Ordinary shares	20,719	0.65 %
GK Gunnar Enge Krossen 1976	Ordinary shares	20,000	0.63 %
KA Karl Anders Øygard 1971	Ordinary shares	20,000	0.63 %
A ARVO INVEST AS	Ordinary shares	17,250	0.54 %
KF Kolbjørn Framhus 1962	Ordinary shares	15,892	0.5 %
A ABAKUS INVEST AS	Ordinary shares	15,071	0.48 %
KM Kjell Magne Driftland 1948	Ordinary shares	15,000	0.47 %
JP Jens Petter Rønning 1945	Ordinary shares	14,594	0.46 %
H HOPEN INVEST AS	Ordinary shares	14,126	0.45 %
3 3T PRODUKTER HOLDING AS	Ordinary shares	12,328	0.39 %
K KLØKTIG INVEST AS	Ordinary shares	12,000	0.38 %
PR Porter Consultancy Rod	Ordinary shares	11,701	0.37 %
TS Thorvald Helmen Steen 1960	Ordinary shares	10,061	0.32 %
JP Jan Petter Øvrehus 1961	Ordinary shares	10,000	0.32 %
P PER STRAND EIENDOM AS	Ordinary shares	9,402	0.3 %
4 4 LB INVEST AS	Ordinary shares	8,533	0.27 %
HM Henning Dybwad-Holmboe Mork 1959	Ordinary shares	8,340	0.26 %
TF Tor Flå 1953	Ordinary shares	8,340	0.26 %
AO Asbjørn Olav Flaa 1937	Ordinary shares	8,333	0.26 %
N NORINNOVA AS	Ordinary shares	8,307	0.26 %
JS John Sigurd Mjøen Svendsen 1958	Ordinary shares	8,127	0.26 %
S SPAREBANK 1 NORD-NORGE PORTEFØLJE AS	Ordinary shares	8,094	0.26 %
V VILLEMHAUGEN INVEST AS	Ordinary shares	7,700	0.24 %
G GREEN ENERGY CONSULTING AS	Ordinary shares	7,500	0.24 %
S SÅKORNINVEST MIDT-NORGE AS	Ordinary shares	7,131	0.23 %
B BÅTSTØ BRUG AS	Ordinary shares	6,900	0.22 %
ØR Øystein Rekdal 1962	Ordinary shares	6,324	0.2 %
K KRÆMER AS	Ordinary shares	5,758	0.18 %
T TAVE INVEST AS	Ordinary shares	5,616	0.18 %
J JESEM AS	Ordinary shares	5,395	0.17 %
B BUGAHEIA HOLDING AS	Ordinary shares	5,150	0.16 %
HR Håkon Rolf Hansen 1941	Ordinary shares	5,100	0.16 %
PA Per Arne Flatberg 1964	Ordinary shares	5,000	0.16 %
CD Christian Driftland 1976	Ordinary shares	5,000	0.16 %
KA Karsten Andre Helland 1976	Ordinary shares	5,000	0.16 %
T TROMS KRAFT AS	Ordinary shares	4,998	0.16 %
H HARILA INVEST AS	Ordinary shares	4,941	0.16 %
Ø ØKSNES INVEST AS	Ordinary shares	4,328	0.14 %
P PAACS INVEST AS	Ordinary shares	4,170	0.13 %
K KRANE AS	Ordinary shares	3,620	0.11 %
M MYRBAKK EIENDOM AS	Ordinary shares	3,620	0.11 %
J JGB CORPORATE AS	Ordinary shares	3,450	0.11 %
H HAUKELAND AS	Ordinary shares	3,403	0.11 %
PW Peter Wilhelm Jebsen 1955	Ordinary shares	3,123	0.1 %
C COLLETT & CO. AS	Ordinary shares	3,100	0.1 %
V VFO INVEST AS	Ordinary shares	3,072	0.1 %
J JPB AS	Ordinary shares	2,917	0.09 %
B BODØ LEGETJENESTER AS	Ordinary shares	2,912	0.09 %
W WEAB INVEST AS	Ordinary shares	2,821	0.09 %
G GADD HOLDING AS	Ordinary shares	2,775	0.09 %
KE Kjell Magne Enoksen 1958	Ordinary shares	2,564	0.08 %
VS Vera Feldt Sandnes 1954	Ordinary shares	2,564	0.08 %
MG Marius Gittesin Gunneng 1969	Ordinary shares	2,561	0.08 %
S SYMBIA AS	Ordinary shares	2,560	0.08 %
S SUNDSVOLD HOLDING AS	Ordinary shares	2,558	0.08 %
KB Kirsti Brendlien 1975	Ordinary shares	2,500	0.08 %
P PONGO AS	Ordinary shares	2,445	0.08 %
GN Gjermund Nordskar 1988	Ordinary shares	2,384	0.08 %
H HÅKON HANSEN AS	Ordinary shares	2,313	0.07 %
S SIRIUS EIENDOM AS	Ordinary shares	2,248	0.07 %
S SUCABE INVEST AS	Ordinary shares	2,147	0.07 %
SS Siw J Skjold Skarsgård 1969	Ordinary shares	2,100	0.07 %
K KARDIOKONSULT AS	Ordinary shares	2,000	0.06 %
E EXACT ESTIMATES AS	Ordinary shares	2,000	0.06 %
P PARG INVEST AS	Ordinary shares	2,000	0.06 %
RS Roger Synnevåg 1992	Ordinary shares	2,000	0.06 %
RB Rudolf Bertham Ulf Vardemann 1967	Ordinary shares	2,000	0.06 %
D DBTECH AS	Ordinary shares	2,000	0.06 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	1,379,500	1,520,225	538,481
Annual Total Result	-1,750,939	-2,187,344	-3,247,715
Total assets	5,180,231	1,424,240	3,471,396
Total liabilities	2,394,909	2,313,211	2,173,024
Total equity	2,785,322	-888,971	1,298,372

P&L

Year	2023	2022	2021
Total operating income	1,379,500	1,520,225	538,481
Total operating costs	2,836,525	3,706,240	3,777,146
Operating result	-1,457,025	-2,186,015	-3,238,665
Financial income/costs	-293,914	-1,328	-9,050
Profit before tax	-1,750,939	-2,187,344	-3,247,715
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	-1,750,939	-2,187,344	-3,247,715

Balance overview

Year	2023	2022	2021
Total fixed assets	16,100	28,976	0
Total current assets	5,164,131	1,395,264	3,471,396
Total assets	5,180,231	1,424,240	3,471,396
Short term debt	1,326,472	989,807	849,620
Long term debt	1,068,437	1,323,404	1,323,404
Total liabilities	2,394,909	2,313,211	2,173,024
Contributed capital	2,785,322	287,078	1,298,372
Retained earnings	0	-1,176,050	0
Total equity	2,785,322	-888,971	1,298,372
Total equity and liabilities	5,180,231	1,424,240	3,471,396

PHARMASUM THERAPEUTICS AS913 746 430